TeamBest Global Consolidates Best ABT Molecular Imaging and Best Cyclotron Systems into Best Cyclotron Systems, Inc.

Cyclo Therapeutics Merges with Applied Molecular Transport; Combined Company to Operate as Cyclo Therapeutics, Inc.

December 27, 2023

Biotechnology

Cyclo Therapeutics completed an all-stock merger with Applied Molecular Transport (AMT), with AMT shareholders receiving 0.1331 shares of Cyclo Therapeutics for each AMT share (approximately 5,822,720 Cyclo shares, or ~18% of the combined company). The combined, Nasdaq-listed company will operate as Cyclo Therapeutics, focus on advancing the Phase 3 TransportNPC study of Trappsol Cyclo for Niemann-Pick Disease Type C1, be led by Cyclo's existing management and headquartered in Gainesville, Florida.

Telix Pharmaceuticals Acquires ARTMS Inc.

March 5, 2024

Pharmaceuticals

Telix Pharmaceuticals Limited has completed the acquisition of ARTMS Inc., a Burnaby, British Columbia-based developer of cyclotron-based isotope production technology and the QUANTM Irradiation System (QIS). The deal strengthens Telix's vertical integration and supply-chain control for key diagnostic and therapeutic radioisotopes (including 89Zr, 68Ga, 99mTc and 64Cu) to support its commercial products and pipeline.

Radon Medical Imaging Acquires Tristate Biomedical Solutions

July 11, 2023

Healthcare Services

Radon Medical Imaging has acquired Tristate Biomedical Solutions (TBS), a Franklin, Ohio-based provider of new, used and refurbished imaging and biomedical equipment with strengths in C-Arms and X-Ray systems. The add-on deal expands Radon's biomedical and C-Arm capabilities and extends its geographic footprint across Ohio, Indiana, Kentucky and Louisiana; Tristate founder Tyler Thornberry will join Radon's leadership and remain a shareholder.

Boston Scientific Acquires BTG plc

August 19, 2019

Medical Devices

Boston Scientific Corporation completed its acquisition of BTG plc by scheme of arrangement, with BTG shareholders receiving 840 pence in cash per share. The purchase brings BTG’s interventional medicine portfolio, specialty pharmaceuticals and licensing business into Boston Scientific, strengthening its capabilities in interventional oncology and vascular therapies.

Cycle Pharmaceuticals (Cycle Group) Acquires Applied Therapeutics, Inc.

February 3, 2026

Pharmaceuticals

Cycle Group Holdings Limited (Cycle Pharmaceuticals) has completed the acquisition of NASDAQ-listed Applied Therapeutics, a clinical-stage biopharmaceutical company focused on novel CNS-penetrant therapies for rare metabolic diseases. The transaction was funded from Cycle's cash on hand and brings Applied's lead candidate govorestat and rare-disease pipeline into Cycle's rare metabolic disease platform.

Alstom Acquires B&C Transit, Inc.

January 26, 2021

Transportation

Alstom has agreed to acquire B&C Transit, Inc., a U.S.-based transit engineering design and construction firm specializing in passenger rail signalling and communications. The acquisition will make B&C Transit a wholly owned subsidiary, strengthening Alstom’s signalling and systems engineering capabilities and expanding its presence on the U.S. West Coast and across North America.